YDC-104

N/A

Report date: 2023/03/12 16:34:24
NME

Base Information

Drug NameYDC-104
Drug Alias NameYDC-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 2B modulators
TargetsEukaryotic translation initiation factor 2B
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYd Global Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYd Global Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A